Discovery of HSD-621 as
a Potential Agent for the
Treatment of Type 2 Diabetes |
| |
| Authors: | Zhao-Kui Wan,Eva Chenail,Huan-Qiu Li,Manus Ipek,Jason Xiang,Vipin Suri,Seung Hahm,Joel Bard,Kristine Svenson,Xin Xu,Xianbin Tian,Mengmeng Wang,Xiangping Li,Christian E. Johnson,Ariful Qadri,Darrell Panza,Mylene Perreault,Tarek S. Mansour,James
F. Tobin,Eddine Saiah |
| |
| Affiliation: | Worldwide Research and Development, PfizerInc., 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States |
| |
| Abstract: | | |
| Keywords: | 11β -hydroxysteroid dehydrogenase type I (HSD1), diet-induced obesity, type II diabetes, piperazinesufonamides |
|
|
